McKesson Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 4, 2026, reporting results for its second fiscal quarter and the first six months of its fiscal year.
Key Highlights
- Quarterly revenues of $110,957 million for the three months ended September 30, 2026, compared to $103,150 million in the same period of 2025, according to the filing.
- Net income attributable to McKesson Corporation of $1,218 million for the three months ended September 30, 2026, versus $1,110 million in the prior-year quarter.
- Diluted earnings per share of $10.44 for the three-month period, compared to $8.92 in the three months ended September 30, 2025.
- Six-month revenues of $216,337 million for the period ended September 30, 2026, up from $200,977 million in the comparable prior-year period.
- Total assets of $92,323 million as of September 30, 2026, compared to $82,323 million as of March 31, 2026.
- 115,456,664 shares of common stock outstanding as of October 30, 2026, per the filing cover page.
- Cash dividends of $0.94 per common share were declared during the three months ended September 30, 2026, as reported in the condensed consolidated statements of stockholders' deficit.
McKesson's Second Quarter Financial Position and Operating Results
McKesson Corporation, a healthcare distribution and services company incorporated in Delaware and headquartered in Irving, Texas, reported second-quarter revenues of $110,957 million and cost of sales of $107,001 million, producing gross profit of $3,956 million for the three months ended September 30, 2026, according to the filing. Operating income for the quarter was $1,604 million, after total operating expenses of $2,352 million. The company trades on the New York Stock Exchange under the symbol NYSE:MCK.
For the six months ended September 30, 2026, the filing reported revenues of $216,337 million and net income of $2,328 million. Net income attributable to noncontrolling interests for the six-month period was $496 million, with net income attributable to McKesson Corporation at $1,832 million. Diluted earnings per common share attributable to McKesson Corporation for the six-month period were $15.53, compared to $15.16 in the six months ended September 30, 2025.
The condensed consolidated balance sheet as of September 30, 2026 showed cash and cash equivalents of $6,528 million, up from $3,975 million at March 31, 2026. Long-term debt stood at $8,414 million, compared to $5,259 million at the prior fiscal year-end. The company reported a total McKesson Corporation stockholders' deficit of $3,954 million as of September 30, 2026, with treasury shares carried at $36,012 million. During the three months ended September 30, 2026, the filing disclosed repurchases of common stock totaling $1,120 million at cost, reducing treasury share count by approximately 1 million shares.
What Was Disclosed
McKesson Corporation disclosed its unaudited condensed consolidated financial statements for the three and six months ended September 30, 2026 in this Form 10-Q, covering income, comprehensive income, balance sheet, stockholders' deficit, and cash flow information, along with accompanying financial notes and management discussion.





Please wait processing your request...